98 filings
8-K
EDIT
Editas Medicine Inc
28 Feb 24
Editas Medicine Announces Fourth Quarter and Full Year 2023 Results and Business Updates
7:06am
8-K
EDIT
Editas Medicine Inc
13 Dec 23
Regulation FD Disclosure
9:02am
8-K
EDIT
Editas Medicine Inc
11 Dec 23
Regulation FD Disclosure
4:23pm
8-K
EDIT
Editas Medicine Inc
22 Nov 23
Departure of Directors or Certain Officers
4:10pm
8-K
EDIT
Editas Medicine Inc
3 Nov 23
Editas Medicine Announces Third Quarter 2023 Results and Business Updates
7:06am
8-K
6m2vr
10 Oct 23
Departure of Directors or Certain Officers
4:05pm
8-K
p4pyair0n0n24 32npyp
2 Aug 23
Editas Medicine Announces Second Quarter 2023 Results and Business Updates
7:16am
8-K
yd5h7vz5x mgpz7vrhn
15 Jun 23
Editas Medicine Announces Offering of Common Stock
4:30pm
8-K
jzxkzw
9 Jun 23
Regulation FD Disclosure
6:01am
8-K
sud6dj rgq
5 Jun 23
Submission of Matters to a Vote of Security Holders
4:15pm
8-K
sic7g 36d2yc
17 May 23
Departure of Directors or Certain Officers
4:30pm
8-K
1uqbp84bjomx80zzp3
5 May 23
Editas Medicine Announces First Quarter 2023 Results and Business Updates
7:16am
8-K
51heoyhg1wtz 0tnjgw7
13 Apr 23
Departure of Directors or Certain Officers
5:09pm
8-K
3tk8xfqvm7 jwh3ezmnn
14 Mar 23
Departure of Directors or Certain Officers
4:45pm
8-K
1unjhw3 yv
22 Feb 23
Editas Medicine Announces Fourth Quarter and Full Year 2022 Results and Business Updates
6:31am
8-K
947mgwu
9 Jan 23
Departure of Directors or Certain Officers
8:36am
8-K
fhdz7l
6 Dec 22
Other Events
6:41am
8-K
d1425xg6fk00wmukc
17 Nov 22
Editas Medicine Announces Clinical Data Demonstrating Proof of Concept of EDIT-101 from Phase 1/2 BRILLIANCE Trial
7:30am
8-K
m7wbvqblszvok041
2 Nov 22
Editas Medicine Announces Third Quarter 2022 Results and Business Updates
6:49am
8-K
64qbhs8geap
3 Aug 22
Editas Medicine Announces Second Quarter 2022 Results and Business Updates
6:46am